Synthesis of intermediate for treprostinil production

US10077225B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10077225-B2
Application numberUS-201715440441-A
CountryUS
Kind codeB2
Filing dateFeb 23, 2017
Priority dateMar 2, 2011
Publication dateSep 18, 2018
Grant dateSep 18, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The compound according to Formula I is an intermediate in the synthesis of prostacylin analogs. The present invention provides an efficient method for synthesizing a Formula I compound.

First claim

Opening claim text (preview).

What is claimed is: 1. In a process of preparing a pharmaceutical product comprising a prostacyclin, wherein the prostacyclin is synthesized from a starting material of Formula I: the improvement comprising: (I) synthesizing a compound of Formula A by: (i) contacting a compound of Formula B with an organolithium; (ii) contacting the lithiated product from step (i) with copper cyanide to form a cuprate; and (iii) contacting the cuprate from step (ii) with an allyl halide selected from the group consisting of allyl chloride, allyl bromide and allyl iodide; and (II) hydrolyzing the compound of Formula A to form the compound of Formula I, wherein, x is an integer between 2 and 4 inclusive; R is selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 6 -C 14 )aryl, and (C 6 -C 14 )aryl(C 1 -C 6 )alkylene-; and R a , R b and R c are each independently selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, (C 6 -C 14 ) aryl, (C 6 -C 14 )aryl(C 1 -C 6 )alkylene, and (C 3 -C 6 )cycloalkyl(C 1 -C 6 )alkylene-. 2. The improvement of claim 1 , wherein R a , R b and R c are each independently (C 1 -C 6 )alkyl. 3. The improvement of claim 2 , wherein R a , R b and R c are each methyl. 4. The improvement of claim 1 , wherein R a is (C 1 -C 6 )alkyl and R b and R c are each independently (C 3 -C 6 )cycloalkyl. 5. The improvement of claim 1 , wherein integer x is 2. 6. The improvement of claim 1 , wherein R is straight or branched (C 1 -C 6 )alkyl. 7. The improvement of claim 1 , wherein R is methyl. 8. The improvement of claim 1 , wherein R is (C 6 -C 14 )aryl(C 1 -C 6 )alkylene-. 9. The improvement of claim 1 , wherein R is benzyl. 10. The improvement of claim 1 , wherein the organolithium is phenyllithium, or butyllithium. 11. The improvement of claim 1 , wherein said hydrolyzing comprises contacting the compound of Formula A with an agent selected from the group consisting of water, aqueous mineral acid, and an aqueous solution of sodium sulfite. 12. The improvement of claim 1 , wherein said hydrolyzing comprises contacting the compound of Formula A with an aqueous solution of sodium sulfite. 13. The improvement of claim 1 , wherein the prostacyclin is treprostinil. 14. In a process of preparing a pharmaceutical product comprising a prostacyclin, wherein the prostacyclin is synthesized from a starting material of Formula I: the improvement comprising: (a) contacting an aldehyde of Formula C with a compound of formula R c R b N—(CHR′) x —NHR a in the presence of an organolithium; wherein x is an integer between 0 and 4 inclusive; R′ is H, R is an alcohol protecting group or is selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 6 -C 14 )aryl, and (C 6 -C 14 )aryl(C 1 -C 6 )alkylene-; and R a , R b and R c are each independently selected from the group consisting of straight or branched (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, (C 6 -C 14 )aryl, (C 6 -C 14 )aryl(C 1 -C 6 )alkylene, and (C 3 -C 6 )cycloalkyl(C 1 -C 6 )alkylene-; (b) contacting the product from step (a) with an organolithium to form an ortho-lithiated product, and then contacting the ortho-lithiated product with copper cyanide to form a cuprate; (c) contacting the cuprate from step (b) with an allyl halide selected from the group consisting of allyl chloride, allyl bromide and allyl iodide; and (d) hydrolyzing the product of step (c) to form the compound of Formula I. 15. The improvement of claim 14 , wherein said organolithium is phenyllithium. 16. The improvement of claim 14 , wherein integer x is 1 and R a , R b and R c are methyl and wherein the allyl halide is allyl iodide. 17. The improvement of claim 14 , wherein the prostacyclin is treprostinil.

Assignees

Inventors

Classifications

  • containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups · CPC title

  • C07C45/42Primary

    by hydrolysis · CPC title

  • by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups · CPC title

  • Preparation of carboxylic acids or their salts, halides or anhydrides (of acids by hydrolysis of oils, fats or waxes C11C) · CPC title

  • by increase in the number of carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10077225B2 cover?
The compound according to Formula I is an intermediate in the synthesis of prostacylin analogs. The present invention provides an efficient method for synthesizing a Formula I compound.
Who is the assignee on this patent?
United Therapeutics Corp
What technology area does this patent fall under?
Primary CPC classification C07C45/42. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).